BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Jensen JL, Sankhala RS, Dussupt V, et al. (2023) Targeting the Spike Receptor Binding Domain Class V Cryptic Epitope by an Antibody with Pan-Sarbecovirus Activity. Journal of Virology. e0159622 |
| Chen WH, Hajduczki A, Martinez EJ, et al. (2023) Shark nanobodies with potent SARS-CoV-2 neutralizing activity and broad sarbecovirus reactivity. Nature Communications. 14: 580 |
| Tsuji I, Vang F, Dominguez D, et al. (2022) Somatic Hypermutation and Framework Mutations of Variable Region Contribute to Anti-Zika Virus-Specific Monoclonal Antibody Binding and Function. Journal of Virology. e0007122 |
| Suryadevara N, Shiakolas AR, VanBlargan LA, et al. (2022) An antibody targeting the N-terminal domain of SARS-CoV-2 disrupts the spike trimer. The Journal of Clinical Investigation |
| Yuan TZ, Garg P, Wang L, et al. (2022) Rapid discovery of diverse neutralizing SARS-CoV-2 antibodies from large-scale synthetic phage libraries. Mabs. 14: 2002236 |
| Dussupt V, Sankhala RS, Mendez-Rivera L, et al. (2021) Low-dose in vivo protection and neutralization across SARS-CoV-2 variants by monoclonal antibody combinations. Nature Immunology |
| Williamson LE, Reeder KM, Bailey K, et al. (2021) Therapeutic alphavirus cross-reactive E1 human antibodies inhibit viral egress. Cell. 184: 4430-4446.e22 |
| Kotaki T, Kurosu T, Grinyo-Escuer A, et al. (2021) An affinity-matured human monoclonal antibody targeting fusion loop epitope of dengue virus with in vivo therapeutic potency. Scientific Reports. 11: 12987 |
| Murin CD, Gilchuk P, Ilinykh PA, et al. (2021) Convergence of a common solution for broad ebolavirus neutralization by glycan cap-directed human antibodies. Cell Reports. 35: 108984 |
| Suryadevara N, Shrihari S, Gilchuk P, et al. (2021) Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein. Cell |